bioRxiv/medRxiv TRiP Review Activity

426 Reviews — All Partners — Cancer Biology

Most recent first Previous |  Page 8: Articles 71-80  | Next

Targeting SLC7A11-mediated cysteine metabolism for the treatment of trastuzumab resistant HER2 positive breast cancer
Hua, Y., Duan, N., Sun, C., Yang, F., Tian, M., Sun, Y., Zhao, S., Gong, J., Liu, Q., Huang, X., Liang, Y., Fu, Z., Li, W., Yin, Y.
10.1101/2024.11.12.623302 — Posted: 2024-11-15 — Discussion: 2025-04-22  eLife
DuoHexaBody-CD37 induces direct cytotoxic signaling in diffuse large B-cell lymphoma
Pal Singh, S., van den Beukel, M. D., van Deventer, S., Overdijk, M. B., Roukens, G., Santegoets, K. C. M., Breij, E. C. W., ter Beest, M., van Spriel, A. B.
10.1101/2025.02.24.639899 — Posted: 2025-02-28 — Discussion: 2025-04-22  eLife
A single cysteine residue in vimentin regulates long non-coding RNA XIST to suppress epithelial-mesenchymal transition and stemness in breast cancer
Usman, S., Yeudall, W. A., Teh, M.-T., Ghaloum, F., Tummala, H., Waseem, A.
10.1101/2024.11.13.623301 — Posted: 2024-11-15 — Discussion: 2025-04-22  eLife
Δ133p53 and Δ160p53 isoforms of the tumor suppressor protein p53 exert dominant-negative effect primarily by co-aggregation
Zhao, L., Punga, T., Sanyal, S.
10.1101/2024.07.23.604790 — Posted: 2024-07-24 — Discussion: 2025-04-17  eLife
RUNX2 Isoform II Protects Cancer Cells from Ferroptosis by Promoting PRDX2 Expression in Oral Squamous Cell Carcinoma
Huang, J., Jia, R., Guo, J.
10.1101/2024.05.17.594656 — Posted: 2024-05-18 — Discussion: 2025-04-17  eLife
VGLL2 and TEAD1 fusion proteins drive YAP/TAZ-independent transcription and tumorigenesis by engaging p300
Guo, S., Hu, X., Cotton, J. L., Ma, L., Li, Q., Cui, J., Wang, Y., Thakare, R. P., Tao, Z., Ip, T., Wu, X., Wang, J., Mao, J.
10.1101/2024.05.01.592016 — Posted: 2024-05-03 — Discussion: 2025-04-14  eLife
Transcriptional pattern enriched for synaptic signaling is associated with shorter survival of patients with high-grade serous ovarian cancer
Bhattacharya, A., Stutvoet, T. S., Perla, M., Loipfinger, S., Jalving, M., Reyners, A. K. L., Vermeer, P. D., Drapkin, R., de Bruyn, M., de Vries, E. G. E., de Jong, S., Fehrmann, R. S. N.
10.1101/2024.10.21.619015 — Posted: 2024-10-24 — Discussion: 2025-04-10  eLife
Oncogenic and teratogenic effects of p53Y217C, a mouse model of the human hotspot mutant p53Y220C
Jaber, S., Eldawra, E., Rakotopare, J., Gabriel, M., Lejour, V., Simeonova, I., Morillon, A., Bardot, B., Toledo, F.
10.1101/2024.09.26.615223 — Posted: 2024-09-29 — Discussion: 2025-03-26  eLife
S100a4+ alveolar macrophages accelerate the progression of precancerous atypical adenomatous hyperplasia by promoting fatty acid metabolism
Huang, H., Yang, Y., Zhang, Q., Yang, Y., Xiong, Z., Mao, S., Song, T., Wang, Y., Liu, Z., Bu, H., Zhang, L., Zhang, L.
10.1101/2024.10.17.618873 — Posted: 2024-10-21 — Discussion: 2025-03-25  eLife
Loss function of tumor suppressor FRMD8 confers resistance to tamoxifen therapy via a dual mechanism
Wu, W., Yu, M., Li, Q., Zhao, Y., Zhang, L., Sun, Y., Wang, Z., Gong, Y., Wang, W., Liu, C., Zhang, J., Tang, Y., Xu, X., Guo, X., Zhan, J., Zhang, H.
10.1101/2024.08.01.606147 — Posted: 2024-08-04 — Discussion: 2025-03-18  eLife

Evaluation Sources